• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

合成和结构活性关系的 botryllamides,其可阻断 ABCG2 多药转运体。

Synthesis and structure-activity relationship of botryllamides that block the ABCG2 multidrug transporter.

机构信息

Laboratory of Microbial Chemistry, College of Pharmaceutical Sciences, Ritsumeikan University, 1-1-1 Noji-Higashi, Kusatsu, Shiga 525-8577, Japan.

出版信息

Bioorg Med Chem Lett. 2010 Feb 15;20(4):1330-3. doi: 10.1016/j.bmcl.2010.01.016. Epub 2010 Jan 11.

DOI:10.1016/j.bmcl.2010.01.016
PMID:20097565
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2848298/
Abstract

In previous work, botryllamides discovered from the marine ascidian Botryllus tyreus were characterized as selective inhibitors of the ABCG2 multidrug transporter. However, the structural basis for this activity could not be established. In this study, botryllamide F, the core botryllamide structure, and botryllamide G, the most potent botryllamide ABCG2 inhibitor, were synthesized along with a series of structural variants for evaluation of structure-activity relationships. The biological activity of synthetic botryllamide analogs implied that the 2-methoxy-p-coumaric acid portion, and the degree of double bond conjugation within this group, were critical for inhibition of ABCG2. However, variations in the substituents on the two aryl groups did not appear to significantly impact the potency or degree of inhibition.

摘要

在之前的工作中,从海洋被囊动物泡叶藻属中发现的 botryllamides 被鉴定为 ABCG2 多药转运蛋白的选择性抑制剂。然而,这种活性的结构基础尚无法确定。在这项研究中,botryllamide F(botryllamide 的核心结构)和 botryllamide G(最有效的 botryllamide ABCG2 抑制剂)以及一系列结构变体被合成,以评估结构-活性关系。合成 botryllamide 类似物的生物学活性表明,2-甲氧基对香豆酸部分以及该基团内双键的共轭程度对于抑制 ABCG2 至关重要。然而,两个芳基上取代基的变化似乎并没有显著影响抑制的效力或程度。

相似文献

1
Synthesis and structure-activity relationship of botryllamides that block the ABCG2 multidrug transporter.合成和结构活性关系的 botryllamides,其可阻断 ABCG2 多药转运体。
Bioorg Med Chem Lett. 2010 Feb 15;20(4):1330-3. doi: 10.1016/j.bmcl.2010.01.016. Epub 2010 Jan 11.
2
Botryllamide G is an ABCG2 inhibitor that improves lapatinib delivery in mouse brain.布氏菌素 G 是一种 ABCG2 抑制剂,可提高拉帕替尼在小鼠脑内的递送。
Cancer Biol Ther. 2020;21(3):223-230. doi: 10.1080/15384047.2019.1683324. Epub 2019 Nov 10.
3
Botryllamides: natural product inhibitors of ABCG2.葡萄状海鞘酰胺:ABCG2的天然产物抑制剂
ACS Chem Biol. 2009 Aug 21;4(8):637-47. doi: 10.1021/cb900134c.
4
Phenolic indeno[1,2-b]indoles as ABCG2-selective potent and non-toxic inhibitors stimulating basal ATPase activity.酚类茚并[1,2 - b]吲哚作为ABCG2选择性强效且无毒的抑制剂,可刺激基础ATP酶活性。
Drug Des Devel Ther. 2015 Jul 3;9:3481-95. doi: 10.2147/DDDT.S84982. eCollection 2015.
5
Hedgehog pathway inhibitor HhAntag691 is a potent inhibitor of ABCG2/BCRP and ABCB1/Pgp.刺猬信号通路抑制剂HhAntag691是ABCG2/BCRP和ABCB1/Pgp的强效抑制剂。
Neoplasia. 2009 Jan;11(1):96-101. doi: 10.1593/neo.81264.
6
AST1306, a potent EGFR inhibitor, antagonizes ATP-binding cassette subfamily G member 2-mediated multidrug resistance.AST1306,一种有效的 EGFR 抑制剂,拮抗 ABCG2 介导的多药耐药。
Cancer Lett. 2014 Aug 1;350(1-2):61-8. doi: 10.1016/j.canlet.2014.04.008. Epub 2014 Apr 18.
7
Linsitinib (OSI-906) antagonizes ATP-binding cassette subfamily G member 2 and subfamily C member 10-mediated drug resistance.林西替尼(OSI-906)可拮抗ATP结合盒转运体G成员2和C成员10介导的耐药性。
Int J Biochem Cell Biol. 2014 Jun;51:111-9. doi: 10.1016/j.biocel.2014.03.026. Epub 2014 Apr 12.
8
Flavonoid structure-activity studies identify 6-prenylchrysin and tectochrysin as potent and specific inhibitors of breast cancer resistance protein ABCG2.类黄酮结构-活性研究表明,6-异戊烯基白杨素和柚皮素是乳腺癌耐药蛋白ABCG2的有效且特异性抑制剂。
Cancer Res. 2005 Jun 1;65(11):4852-60. doi: 10.1158/0008-5472.CAN-04-1817.
9
Lapatinib (Tykerb, GW572016) reverses multidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2.拉帕替尼(泰立沙,GW572016)通过抑制ATP结合盒亚家族B成员1和G成员2的活性来逆转癌细胞中的多药耐药性。
Cancer Res. 2008 Oct 1;68(19):7905-14. doi: 10.1158/0008-5472.CAN-08-0499.
10
Sunitinib (Sutent, SU11248), a small-molecule receptor tyrosine kinase inhibitor, blocks function of the ATP-binding cassette (ABC) transporters P-glycoprotein (ABCB1) and ABCG2.舒尼替尼(索坦,SU11248)是一种小分子受体酪氨酸激酶抑制剂,可阻断ATP结合盒(ABC)转运蛋白P-糖蛋白(ABCB1)和ABCG2的功能。
Drug Metab Dispos. 2009 Feb;37(2):359-65. doi: 10.1124/dmd.108.024612. Epub 2008 Oct 29.

引用本文的文献

1
Creating and screening natural product libraries.天然产物文库的构建与筛选。
Nat Prod Rep. 2020 Jul 1;37(7):893-918. doi: 10.1039/c9np00068b. Epub 2020 Mar 18.
2
Botryllamide G is an ABCG2 inhibitor that improves lapatinib delivery in mouse brain.布氏菌素 G 是一种 ABCG2 抑制剂,可提高拉帕替尼在小鼠脑内的递送。
Cancer Biol Ther. 2020;21(3):223-230. doi: 10.1080/15384047.2019.1683324. Epub 2019 Nov 10.
3
Ascidian Toxins with Potential for Drug Development.具有药物开发潜力的贻贝毒素。
Mar Drugs. 2018 May 13;16(5):162. doi: 10.3390/md16050162.
4
Marine Natural Products as Models to Circumvent Multidrug Resistance.海洋天然产物作为克服多药耐药性的模型。
Molecules. 2016 Jul 8;21(7):892. doi: 10.3390/molecules21070892.
5
Marine natural products as breast cancer resistance protein inhibitors.海洋天然产物作为乳腺癌耐药蛋白抑制剂
Mar Drugs. 2015 Apr 3;13(4):2010-29. doi: 10.3390/md13042010.
6
Bioactive dehydrotyrosyl and dehydrodopyl compounds of marine origin.海洋来源的生物活性脱羟酪氨酸和脱羟多巴胺化合物。
Mar Drugs. 2010 Dec 6;8(12):2906-35. doi: 10.3390/md8122906.

本文引用的文献

1
Botryllamides: natural product inhibitors of ABCG2.葡萄状海鞘酰胺:ABCG2的天然产物抑制剂
ACS Chem Biol. 2009 Aug 21;4(8):637-47. doi: 10.1021/cb900134c.
2
ABC drug transporters as molecular targets for the prevention of multidrug resistance and drug-drug interactions.ABC药物转运蛋白作为预防多药耐药和药物-药物相互作用的分子靶点。
Curr Drug Deliv. 2007 Oct;4(4):324-33. doi: 10.2174/156720107782151241.
3
ABCG2: determining its relevance in clinical drug resistance.ABCG2:确定其在临床耐药性中的相关性。
Cancer Metastasis Rev. 2007 Mar;26(1):39-57. doi: 10.1007/s10555-007-9042-6.
4
Modulation of the function of the multidrug resistance-linked ATP-binding cassette transporter ABCG2 by the cancer chemopreventive agent curcumin.癌症化学预防剂姜黄素对多药耐药相关ATP结合盒转运蛋白ABCG2功能的调节作用
Mol Cancer Ther. 2006 Aug;5(8):1995-2006. doi: 10.1158/1535-7163.MCT-06-0087.
5
A high-throughput cell-based assay for inhibitors of ABCG2 activity.一种基于细胞的ABCG2活性抑制剂高通量检测方法。
J Biomol Screen. 2006 Mar;11(2):176-83. doi: 10.1177/1087057105284576. Epub 2006 Feb 20.
6
Evolution of the ATP-binding cassette (ABC) transporter superfamily in vertebrates.脊椎动物中ATP结合盒(ABC)转运蛋白超家族的进化
Annu Rev Genomics Hum Genet. 2005;6:123-42. doi: 10.1146/annurev.genom.6.080604.162122.
7
Total synthesis of dictyodendrin B.网枝树素B的全合成
J Am Chem Soc. 2005 Aug 24;127(33):11620-1. doi: 10.1021/ja0541175.
8
ABCG2 (BCRP) expression in normal and malignant hematopoietic cells.ABCG2(乳腺癌耐药蛋白)在正常和恶性造血细胞中的表达。
Hematol Oncol. 2003 Sep;21(3):115-30. doi: 10.1002/hon.714.
9
The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria.乳腺癌耐药蛋白可抵御一种主要的叶绿素衍生饮食光毒素及原卟啉症。
Proc Natl Acad Sci U S A. 2002 Nov 26;99(24):15649-54. doi: 10.1073/pnas.202607599. Epub 2002 Nov 12.
10
Total syntheses of (+/-)-anchinopeptolide D and (+/-)-cycloanchinopeptolide D.(±)-安奇诺肽D和(±)-环安奇诺肽D的全合成
J Org Chem. 2000 Feb 11;65(3):793-800. doi: 10.1021/jo991454l.